Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 267, Issue 7, pp 1019–1026 | Cite as

Thyroid incidentalomas: to treat or not to treat

  • N. G. Iyer
  • Ashok R. Shaha
  • Carl E. Silver
  • Kenneth O. Devaney
  • Alessandra Rinaldo
  • Phillip K. Pellitteri
  • Alfio Ferlito
REVIEW ARTICLE

Abstract

Incidental lesions of the thyroid gland are an increasing problem facing clinicians. While asymptomatic palpable lesions are detected in only 4–7% of the population, currently available imaging modalities are sensitive enough to detect lesions in 20–30% of the population. Guidelines for managing these incidentalomas are limited, largely due to lack of well-powered prospective studies. This review will address the currently available data on thyroid incidentalomas, detected through clinical examination, cross-sectional imaging, ultrasound, and PET scans. We will focus on the modalities of detection and risk of malignancy, further investigation and management options and the deficiencies therein. We propose a pragmatic algorithm when faced with this clinical dilemma under differing circumstances.

Keywords

Incidental lesions Thyroid Ultrasound PET Management 

References

  1. 1.
    Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167CrossRefPubMedGoogle Scholar
  2. 2.
    Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56:531–538CrossRefPubMedGoogle Scholar
  3. 3.
    Wang C, Crapo LM (1997) The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26:189–218CrossRefPubMedGoogle Scholar
  4. 4.
    Mortensen JD, Woolner LB, Bennett WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280CrossRefPubMedGoogle Scholar
  5. 5.
    Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96278 unselected employees. Thyroid 14:926–932CrossRefPubMedGoogle Scholar
  6. 6.
    Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRefPubMedGoogle Scholar
  7. 7.
    Atli M, Akgul M, Saryal M, Daglar G, Yasti AC, Kama NA (2006) Thyroid incidentalomas: prediction of malignancy and management. Int Surg 91:237–244PubMedGoogle Scholar
  8. 8.
    Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537–540PubMedGoogle Scholar
  9. 9.
    Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493CrossRefGoogle Scholar
  10. 10.
    Gough J, Scott-Coombes D, Fausto Palazzo F (2008) Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg 32:1264–1268CrossRefPubMedGoogle Scholar
  11. 11.
    Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton CR Jr, Zeiger MA, Zini M (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63–102PubMedGoogle Scholar
  12. 12.
    Shetty SK, Maher MM, Hahn PF, Halpern EF, Aquino SL (2006) Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR Am J Roentgenol 187:1349–1356CrossRefPubMedGoogle Scholar
  13. 13.
    Youserm DM, Huang T, Loevner LA, Langlotz CP (1997) Clinical and economic impact of incidental thyroid lesions found with CT and MR. AJNR Am J Neuroradiol 18:1423–1428PubMedGoogle Scholar
  14. 14.
    Lee SK, Rho BH (2009) Follicular thyroid carcinoma with an eggshell calcification: report of 3 cases. J Ultrasound Med 28:801–806PubMedGoogle Scholar
  15. 15.
    Steele SR, Martin MJ, Mullenix PS, Azarow KS, Andersen CA (2005) The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Arch Surg 140:981–985CrossRefPubMedGoogle Scholar
  16. 16.
    Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN (2006) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 22:231–238 discussion 239-240CrossRefPubMedGoogle Scholar
  17. 17.
    Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR (2007) FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 14:239–247CrossRefPubMedGoogle Scholar
  18. 18.
    Bae JS, Chae BJ, Park WC, Kim JS, Kim SH, Jung SS, Song BJ (2009) Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol 7:63CrossRefPubMedGoogle Scholar
  19. 19.
    Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ (2007) The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 28:373–381CrossRefPubMedGoogle Scholar
  20. 20.
    Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, Shen YY, Su CT, Kao CH (2005) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 25:1421–1426PubMedGoogle Scholar
  21. 21.
    Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF (2001) Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130:941–946CrossRefPubMedGoogle Scholar
  22. 22.
    Ishimori T, Patel PV, Wahl RL (2005) Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46:752–757PubMedGoogle Scholar
  23. 23.
    Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, Jeong SY, Kim SW (2003) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88:4100–4104CrossRefPubMedGoogle Scholar
  24. 24.
    Katz SC, Shaha A (2008) PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 207:259–264CrossRefPubMedGoogle Scholar
  25. 25.
    Cohen R, Bihan H, des Guetz G, Wind P, Martin A (2009) F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review. Ann Endocrinol (Paris) 70:468-472Google Scholar
  26. 26.
    Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT (2006) Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 47:609–615PubMedGoogle Scholar
  27. 27.
    Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR (2007) Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol 14:3210–3215CrossRefPubMedGoogle Scholar
  28. 28.
    Leenhardt L, Hejblum G, Franc B, Fediaevsky LD, Delbot T, Le Guillouzic D, Menegaux F, Guillausseau C, Hoang C, Turpin G, Aurengo A (1999) Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 84:24–28CrossRefPubMedGoogle Scholar
  29. 29.
    Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103:2269–2273CrossRefPubMedGoogle Scholar
  30. 30.
    Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, Shong YK (2004) Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 60:21–28CrossRefGoogle Scholar
  31. 31.
    Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941–1946CrossRefPubMedGoogle Scholar
  32. 32.
    Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381–387CrossRefPubMedGoogle Scholar
  33. 33.
    Nam SY, Roh JL, Kim JS, Lee JH, Choi SH, Kim SY (2007) Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin Endocrinol (Oxf) 67:135–139CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • N. G. Iyer
    • 1
  • Ashok R. Shaha
    • 1
  • Carl E. Silver
    • 2
  • Kenneth O. Devaney
    • 3
  • Alessandra Rinaldo
    • 4
  • Phillip K. Pellitteri
    • 5
  • Alfio Ferlito
    • 4
  1. 1.Head and Neck ServiceMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Departments of Surgery and Otolaryngology-Head Neck Surgey, Montefiore Medical CenterAlbert Einstein College of MedicineBronxUSA
  3. 3.Department of PathologyAllegiance HealthJacksonMIUSA
  4. 4.Department of Surgical Sciences, ENT ClinicAzienda Ospedaliero-Universitaria di UdineUdineItaly
  5. 5.Department of Otolaryngology-Head and Neck SurgeryGeisinger Medical CenterDanvilleUSA

Personalised recommendations